22/11/2026 02:45 PM
Aspetar and Qatar Anti-Doping Agency Organise National Therapeutic Use Exemption Workshop
Aspetar, Orthopaedic and Sports Medicine Hospital, in collaboration with the Qatar Anti-Doping Agency (QADA), will organise the National Therapeutic Use Exemption (TUE) Workshop 2026 on 12 December 2026. The workshop will be held online from 10:00 a.m. to 2:00 p.m., bringing together healthcare professionals and experts in sports medicine and anti-doping.
The workshop aims to strengthen healthcare professionals’ understanding of Therapeutic Use Exemptions and the procedures required when athletes need to use prohibited medications or treatments for legitimate medical reasons. It will support appropriate athlete care while promoting compliance with international anti-doping regulations.
The scientific programme will cover key areas including TUE criteria and application pathways, medication status checks, permitted treatment alternatives, and the medical and diagnostic evidence required to support TUE applications. Participants will also engage with practical clinical cases and examine common documentation challenges encountered during the application process.
The workshop will also address relevant updates to the International Standard for Therapeutic Use Exemptions (ISTUE) and guidance from the World Anti-Doping Agency (WADA), with sessions delivered by specialists in sports medicine and anti-doping.
Through this initiative, Aspetar and QADA continue their joint efforts to promote best practice in athlete healthcare and anti-doping, while providing healthcare professionals with the knowledge and practical tools needed to manage TUE applications effectively and in accordance with international standards.
Registration for the workshop is now open to physicians and allied healthcare professionals interested in strengthening their knowledge of Therapeutic Use Exemptions and anti-doping requirements. Participants can register online through Aspetar website.
About Aspetar:
Aspetar is a world-leading specialised orthopaedic and sports medicine hospital and the first of its kind in the Middle East. Since 2007, with a world expert team, the hospital has provided top-level comprehensive medical treatment to all athletes in a state-of-the-art facility that sets new standards internationally.
In 2009, Aspetar was accredited as a “FIFA Medical Centre of Excellence” by F-MARC. In 2013, Aspetar was adopted as a reference collaborator centre by the Gulf Countries Council (GCC) Health Ministers Council and “The IOC Research Centre for Prevention of Injury and Protection of Athlete Health” in 2014.
In 2015, Aspetar has been recognised as the “IHF Reference Centre for Athlete and Referee Health”. In the same year, the hospital also achieved obtained-on December 15 the Accreditation Canada International (ACI) “Platinum Level”.
Aspetar is a member–organisation of Aspire Zone Foundation, Qatar’s innovative sports and healthy lifestyle destination.